Literature DB >> 2442249

Functionally distinct agretopic and epitopic sites. Analysis of the dominant T cell determinant of moth and pigeon cytochromes c with the use of synthetic peptide antigens.

B S Fox, C Chen, E Fraga, C A French, B Singh, R H Schwartz.   

Abstract

The dominant T cell determinant on moth and pigeon cytochromes c in B10.A (E beta k:E alpha k) mice is located in the C-terminal portion of the protein, contained within residues 93-103 or 93-104. Thirty-seven antigen analogs, containing single amino acid substitutions at positions 98, 99, 101, 102, 103, and 104, were synthesized. The effects of the substitutions on in vitro antigenicity and in vivo immunogenicity were determined. Functional assays with T cell clones identified residues 99, 101, 102, and 103 as critical, based on their effect on antigenic potency. Peptides containing substitutions at residues 99, 101, and 102 were capable of eliciting unique clones upon immunization of B10.A mice. This was consistent with the identification of these residues as part of the epitope, the site on the antigen that interacts with the T cell receptor. Immunization with peptides substituted at residue 103, however, failed to elicit clones with unique specificity for the immunogen. When these peptides were tested for their ability to stimulate the T cell clones with antigen-presenting cells from B10.A(5R) mice expressing the E beta b:E alpha k Ia molecule, a consistent change in the relative antigenic potency was observed with 50% of the peptides. The effect of the Ia molecule on the antigenic potency ruled out the possibility that residue 103 nonspecifically affected antigen uptake or processing and identified residue 103 as part of the agretope, the site that interacts with the Ia molecule. The locations of the agretope and the epitope on this antigenic determinant appear to be fixed, even in the presence of large numbers of amino acid substitutions. However, some substitutions were found to affect both the agretope and the epitope, placing limits on the functional independence of the two sites. The results are discussed in terms of the trimolecular complex model of T cell activation and the implications of these data for antigen-Ia molecule interactions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442249

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Distinct recognition by two subsets of T cells of an MHC class II-peptide complex.

Authors:  Zheng Pu; Javier A Carrero; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

Review 2.  Structural requirements for the interaction between class II MHC molecules and peptide antigens.

Authors:  A Sette; S Buus; E Appella; L Adorini; H M Grey
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

3.  Hindrance of binding to class II major histocompatibility complex molecules by a single amino acid residue contiguous to a determinant leads to crypticity of the determinant as well as lack of response to the protein antigen.

Authors:  I S Grewal; K D Moudgil; E E Sercarz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 4.  The antigen-major histocompatibility complex-T cell receptor interaction. A structural analysis.

Authors:  W V Williams; D B Weiner; S Wadsworth; M I Greene
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

5.  Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness.

Authors:  K Matsui; J J Boniface; P Steffner; P A Reay; M M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

6.  Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists.

Authors:  D M Page; J Alexander; K Snoke; E Appella; A Sette; S M Hedrick; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Single amino acid residues in a synthetic peptide of influenza haemagglutinin, HA 1 177-199, distinguish I-Ad- and I-Ed-restricted T-cell epitopes.

Authors:  B C Barnett; I Hartlmayr; C M Graham; D B Thomas
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

8.  A strategy for making synthetic peptide vaccines.

Authors:  K Ogasawara; H Naruse; Y Itoh; T Gotohda; J Arikawa; H Kida; R A Good; K Onoé
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

9.  T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.

Authors:  E W Ehrich; B Devaux; E P Rock; J L Jorgensen; M M Davis; Y H Chien
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

10.  Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.

Authors:  H Bhayani; Y Paterson
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.